The Endoscope Detergents And Disinfectants Market is estimated to be valued at USD 782.5 million in 2025 and is projected to reach USD 1203.7 million by 2035, registering a compound annual growth rate (CAGR) of 4.4% over the forecast period.
The endoscope detergents and disinfectants market is experiencing consistent growth, driven by heightened emphasis on reprocessing efficacy and compliance with global sterilization standards. The rising adoption of minimally invasive procedures has elevated the demand for safe and reliable cleaning agents to ensure the sterility of flexible and rigid endoscopes. Regulatory agencies and healthcare accreditation bodies are reinforcing the adoption of high-efficacy, material-safe formulations that minimize instrument wear while ensuring microbial elimination.
Advancements in enzymatic, neutral-pH, and biodegradable disinfectants are enabling broader usage across different reprocessing systems. Additionally, the expansion of centralized sterile services departments (CSSDs) and automated endoscope reprocessors (AERs) is supporting increased use of specialized cleaning chemistries. Future growth is expected to be fueled by rising outpatient endoscopy volumes, particularly in emerging markets where surgical infrastructure modernization is underway.
Hospitals and diagnostic centers are progressively adopting protocol-driven disinfection cycles, further cementing the role of high-performance detergents and disinfectants.
The market is segmented by Chemical Property, Potency Level, and End User and region. By Chemical Property, the market is divided into Neutral, Acidic, Alkaline, and Enzymatic. In terms of Potency Level, the market is classified into High-Level Disinfectants, Low-Level Disinfectants, and Medium-Level Disinfectants.
Based on End User, the market is segmented into Hospitals, Diagnostic Centers, and Clinics. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
Neutral formulations are anticipated to hold a 34.0% revenue share of the endoscope detergents and disinfectants market in 2025. This segment's growth is attributed to its compatibility with sensitive endoscope materials and its ability to maintain cleaning performance without causing corrosion or degradation.
Neutral pH solutions reduce the risk of damage to internal channels and optical components, thereby extending device life and reducing total ownership costs for healthcare providers. These formulations are also preferred for their user safety profile, as they are less likely to cause skin irritation or generate harmful fumes compared to highly acidic or alkaline alternatives. Their efficacy in enzymatic and manual cleaning cycles has made them a standard in both manual pre-cleaning and automated washer-disinfectors.
As healthcare institutions aim to balance safety, performance, and cost, neutral detergents are expected to see sustained adoption across diverse reprocessing workflows.
High-level disinfectants are projected to account for 48.0% of the total market revenue in 2025, emerging as the leading potency segment. Their dominance is being driven by stringent regulatory standards that mandate high-level disinfection for semi-critical medical devices such as endoscopes. These formulations are capable of eliminating a broad spectrum of microorganisms, including bacteria, viruses, fungi, and mycobacteria, without requiring terminal sterilization.
Their compatibility with automated reprocessing systems and compliance with CDC, FDA, and ISO disinfection guidelines have positioned them as the preferred solution in clinical settings. High-level disinfectants also offer rapid turnaround times and low residue properties, supporting efficient endoscope reusability within high-throughput surgical environments.
With increasing scrutiny around infection control, especially in gastrointestinal and pulmonary procedures, high-level formulations remain essential for ensuring patient safety and regulatory compliance.
Hospitals are expected to hold the largest share of the endoscope detergents and disinfectants market in 2025, with a projected revenue contribution of 52.0%. This dominance is underpinned by the large volume of endoscopic procedures conducted in hospital operating rooms, intensive care units, and diagnostic departments.
Hospitals face rigorous oversight in infection prevention and are typically equipped with centralized reprocessing units that demand high-quality detergents and disinfectants. The requirement for compliance with standards such as AAMI ST91, Joint Commission accreditation, and hospital infection control protocols further drives the consistent use of validated cleaning chemistries.
Additionally, hospital procurement strategies prioritize products that offer traceability, validated compatibility with endoscope models, and documented microbial efficacy. As healthcare systems globally focus on improving surgical outcomes and minimizing procedural complications, hospitals remain the primary drivers of demand in the endoscope reprocessing ecosystem.
Several factors are fueling the expansion of the endoscope detergent and disinfectant market; they can be summarized as follows:
Although the expert analysts at FMI have revealed growth-propelling factors in the prevailing endoscope and disinfectants market, some aspects are also identified to inhibit the growth of the market. They are:
The healthcare policies such as Medicaid and Medicare have kept the costs associated with Healthcare-associated Infections (HAIs), including SSIs, out of coverage. Hence, the patients have to pay it out of their pocket, which is a major factor restricting the growth of the market.
North America is currently dominating the market and is projected to account for a total of 35.1% market share of endoscopes and disinfectants during the forecast period.
The USA is a leading country in North America, which is surging the market by collecting huge revenue in recent years. In addition to this, the demand for safe and effective surgical procedures has been rising in the US over the last few years, with over 15 million endoscopy procedures performed annually. This is propelling the endoscope detergents and disinfectants market size in the coming years.
Europe is projected to follow the North American region and hold a significant market share of 29.1% in the forum among all the regions during the forecast period.
Due to the rising numbers of healthcare infrastructure and the presence of rising patients and geriatric populations in the region, it is likely to impact the market in the long run for Europe. With increasing age, gastrointestinal (GI) related diseases increase. The endoscope is used in the diagnosis and treatment of GI-related diseases.
| Segment | QuaternaryAmmonium Compounds (By Type) |
|---|---|
| Market Share in Base Year | 31.4% |
| Attributing Reasons | These compounds aid in controlling the spread of healthcare-associated infections in hospitals and clinics |
| Segment | Medical Device Disinfectant (By Product) |
|---|---|
| Market Share in Base Year | 45.7% |
| Attributing Reasons | The increasing number of surgical procedures across the globe may be considered to be one of the major reasons for driving the segment over the forecast period. |
| Segment | Business to Business (By Sales Channel) |
|---|---|
| Market Share in Base Year | 65.1% |
| Attributing Reasons | Medical device disinfectants, enzymatic cleaners, and surface disinfectants are major antiseptics and disinfectants highly marketed under the B2B sales channel. |
| Segment | Hospital (By End-Use) |
|---|---|
| Market Share in Base Year | 46.2% |
| Attributing Reasons | The increasing incidence of hospital-acquired infections across the globe is one of the major reasons for segment growth over the forecast period. |
The technology in medicine is popped out by the various clinical and Research and Development institutions. Nowadays, start-up companies are interested in making unique devices to help patients throughout their treatment and recovery. This is likely to increase the opportunities in the endoscope detergents market in recent years.
| Start-up Company | EnVision Endoscopy |
|---|---|
| Base Country and Year | USA-based Start-up, 2020 |
| Developments | The start-up provides various clinical surgeries with innovative and effective solutions. They are developing endoscopic surgery devices to help patients to recover their health with minimal expense. However, the company is developing a low-cost IGSS (Image Guided Suturing System) for managing gastrointestinal defects. |
| Start-up Company | MiWendo |
|---|---|
| Base Country and Year | Spain-based Start-up, 2020 |
| Developments | The company is using microwave technology with a safe electromagnetic that is used to attach at conventional colonoscopy. Hence, it helps to detect polyps 360 Degrees and benign tissues |
The key players are focusing on the product, which hits consumers desires. These players are adopting various methods to acquire a maximum share of the market, some of them are mergers, acquisitions, and product launches.
Recent Developments in the Endoscope Detergents and Disinfectants:
The newly adopted robotic systems were introduced in telesurgery in recent years. The first of this surgery is called the Lindbergh operation, which is a more effective and innovative surgery.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 4.4% from 2025 to 2035 |
| Base Year for Estimation | 2024 |
| Historical Data | 2020 to 2024 |
| Forecast Period | 2025 to 2035 |
| Quantitative Units | Revenue in USD million and CAGR from 2025 to 2035 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Chemical Properties, Potency, End User, Region |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia &, New Zealand, China, India, ASIAN, GCC Countries, South Africa |
| Key Companies Profiled | MEDIVATORS Inc., STERIS plc, Borer Chemie AG, Cantel Medical, Getinge AB, Olympus Corporation, Vesimin Health, MDD Company GmbH, Georg Pauldrach, SIRMAXO CHEMICALS PVT.LTD, Serim Research Corporation |
| Customization | Available Upon Request |
The global endoscope detergents and disinfectants market is estimated to be valued at USD 782.5 million in 2025.
It is projected to reach USD 1203.7 million by 2035.
The market is expected to grow at a 4.4% CAGR between 2025 and 2035.
The key product types are neutral, acidic, alkaline and enzymatic.
high-level disinfectants segment is expected to dominate with a 48.0% industry share in 2025.
Explore Similar Insights
Endoscope Detergents And Disinfectants Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
